A Pilot Study Evaluating a Novel Magneto-Fluidic System for Ultra-High Throughput Detection of Circulating Tumor Cells in Patients with Metastatic and Loco-regional Urothelial Bladder Cancer IUSCC-0552
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: bladder cancer
Age: Between 18 - 100 Years
Gender: Male or Female
Patients must have histologically confirmed advanced urothelial bladder cancer, specifically metastatic or muscle invasive disease
Previously untreated patients and patients with prior therapies will be allowed as long as therapy was give > or = 3 weeks prior to blood collection